Wegovy’s impact on patients taking antidepressants

According to a new post-hoc analysis, Novo Nordisk’s weight-loss drug semaglutide, also known as Wegovy, was just as effective among patients taking antidepressants compared to those who weren’t. However, health experts caution that more research is needed to fully understand how the drug affects patients with mental health conditions.

Decision guide: Weight Management Programs

Semaglutide similarly effective for patients on antidepressants

Semaglutide is a drug that mimics a hormone called glucagon-like peptide-1 (GLP-1) to target areas of the brain that regulate appetite and food intake. The drug is available in two forms: Ozempic, a diabetes treatment, and Wegovy, a higher dose...